Prostate Cancer
Opportunistic Prostate Cancer Screening with Biparametric Magnetic Resonance Imaging (VISIONING).
February 27, 2024
Variation in communication of side effects in prostate cancer treatment consultations.
February 27, 2024
Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes.
February 27, 2024
Diffuse Pneumonitis after Lutetium-177-PSMA-617 Treatment in a Patient with Metastatic Castration-Resistant Prostate Cancer.
February 27, 2024
Updated 5-year results for short course abiraterone acetate and LHRH agonist for unfavorable intermediate and favorable high-risk prostate cancer.
February 26, 2024
Prostate Cancer Detection Rate of Transperineal Prostate Biopsy: Cognitive Versus Software Fusion, A Multicenter Analysis.
February 26, 2024
Prostate-specific membrane antigen-positron emission tomography (PSMA-PET) of prostate cancer: current and emerging applications.
February 26, 2024
A Proposal for the Comprehensive Care of Men on Androgen Deprivation Therapy: Recommendations From the Multidisciplinary Prostate Cancer 360 Working Group.
February 23, 2024
Inherited Mutations in DNA Damage Repair Genes in Italian Men with Metastatic Prostate Cancer: Results from the Meet-URO 10 Study.
February 23, 2024
Incidence and survival of secondary malignancies after external beam radiotherapy for prostate cancer in the Surveillance, Epidemiology, and End Results database.
February 23, 2024
Clinical implications of AR alterations in advanced prostate cancer: a multi-institutional collaboration.
February 23, 2024
Reversibility of Bicalutamide PSMA PET-Positive Gynecomastia With Androgen Deprivation Therapy.
February 22, 2024
Gold nanoshells for prostate cancer treatment: evidence for deposition in abdominal organs.
February 22, 2024
Stereotactic ablative radiation therapy in metastatic prostate cancer.
February 22, 2024